CNS Pharmaceuticals, Inc. (CNSP)
4.97
+0.22
(+4.63%)
USD |
NASDAQ |
Oct 23, 16:00
4.97
0.00 (0.00%)
After-Hours: 20:00
CNS Pharmaceuticals Price to Book Value : 0.3991 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 0.3991 |
| October 22, 2026 | 0.3814 |
| October 21, 2026 | 0.3874 |
| October 20, 2026 | 0.4007 |
| October 19, 2026 | 0.4007 |
| October 16, 2026 | 0.3895 |
| October 15, 2026 | 0.4157 |
| October 14, 2026 | 0.4296 |
| October 13, 2026 | 0.4296 |
| October 12, 2026 | 0.4167 |
| October 09, 2026 | 0.4296 |
| October 08, 2026 | 0.4296 |
| October 07, 2026 | 0.436 |
| October 06, 2026 | 0.4257 |
| October 05, 2026 | 0.4256 |
| October 02, 2026 | 0.4276 |
| October 01, 2026 | 0.4208 |
| September 30, 2026 | 0.4256 |
| September 29, 2026 | 0.394 |
| September 28, 2026 | 0.4103 |
| September 25, 2026 | 0.3959 |
| September 24, 2026 | 0.4135 |
| September 23, 2026 | 0.4135 |
| September 22, 2026 | 0.4207 |
| September 21, 2026 | 0.419 |
| Date | Value |
|---|---|
| September 18, 2026 | 0.4103 |
| September 17, 2026 | 0.4111 |
| September 16, 2026 | 0.4416 |
| September 15, 2026 | 0.4577 |
| September 14, 2026 | 0.4577 |
| September 11, 2026 | 0.4689 |
| September 10, 2026 | 0.4617 |
| September 09, 2026 | 0.4641 |
| September 08, 2026 | 0.477 |
| September 04, 2026 | 0.4601 |
| September 03, 2026 | 0.4727 |
| September 02, 2026 | 0.4826 |
| September 01, 2026 | 0.4731 |
| August 31, 2026 | 0.4802 |
| August 28, 2026 | 0.4435 |
| August 27, 2026 | 0.443 |
| August 26, 2026 | 0.4368 |
| August 25, 2026 | 0.4657 |
| August 24, 2026 | 0.477 |
| August 21, 2026 | 0.4681 |
| August 20, 2026 | 0.4818 |
| August 19, 2026 | 0.4681 |
| August 18, 2026 | 0.4707 |
| August 17, 2026 | 0.4336 |
| August 14, 2026 | 0.4432 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.793 |
| Corcept Therapeutics, Inc. | 13.13 |
| Veru, Inc. | 1.346 |
| Johnson & Johnson | 7.789 |
| Eli Lilly & Co. | 35.39 |
Price to Book Value Related Metrics
| Price | 4.97 |
| Earnings Yield | -474.7% |
| Market Cap | 7.263M |